Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

CANCER GENOMICS

The genomic landscape of advanced cancer

Nature Cancer volume 1, pages 372–373 (2020)Cite this article

Subjects

Despite recent advances in cancer treatment, metastasis and therapy resistance remain among the major causes of cancer-related deaths worldwide. A recent pan-cancer study provides a comprehensive molecular profile of advanced and post-therapy tumors, integrating whole-genome and transcriptomic analysis with clinical outcomes.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: The POG570 advanced and post-therapy pan-cancer cohort.

References

  1. Bailey, M. H. et al. Cell 174, 1034–1035 (2018).

    Article  CAS  Google Scholar 

  2. ICGC/TCGA Pan-Cancer Analysis of Whole Genomes Consortium. Nature 578, 82–93 (2020).

    Article  Google Scholar 

  3. Pleasance, E. et al. Nat. Cancer https://doi.org/10.1038/s43018-020-0050-6 (2020).

  4. Robinson, D. R. et al. Nature 548, 297–303 (2017).

    Article  CAS  Google Scholar 

  5. Zehir, A. et al. Nat. Med. 23, 703–713 (2017).

    Article  CAS  Google Scholar 

  6. Priestley, P. et al. Nature 575, 210–216 (2019).

    Article  CAS  Google Scholar 

  7. Lambert, A. W., Pattabiraman, D. R. & Weinberg, R. A. Cell 168, 670–691 (2017).

    Article  CAS  Google Scholar 

  8. Alexandrov, L. B. et al. Nature 578, 94–101 (2020).

    Article  CAS  Google Scholar 

  9. Pich, O. et al. Nat. Genet. 51, 1732–1740 (2019).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

E.R. is supported by funds from the Massachusetts General Hospital Cancer Center, The Breast Cancer Alliance, and the Broad Institute.

Author information

Authors and Affiliations

  1. Center for Cancer Research, Massachusetts General Hospital, Charlestown, MA, USA

    Esther Rheinbay

  2. Harvard Medical School, Boston, MA, USA

    Esther Rheinbay

  3. The Broad Institute of MIT and Harvard, Cambridge, MA, USA

    Esther Rheinbay

Authors
  1. Esther Rheinbay
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Esther Rheinbay.

Ethics declarations

Competing interests

The author declares no competing interests

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rheinbay, E. The genomic landscape of advanced cancer. Nat Cancer 1, 372–373 (2020). https://doi.org/10.1038/s43018-020-0057-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s43018-020-0057-z

This article is cited by

Search

Advanced search

Quick links

Nature Briefing: Cancer

Sign up for the Nature Briefing: Cancer newsletter — what matters in cancer research, free to your inbox weekly.

Get what matters in cancer research, free to your inbox weekly. Sign up for Nature Briefing: Cancer